<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e> (ACH), the most common form of <z:hpo ids='HP_0008873'>short-limbed dwarfism</z:hpo>, and its related disorders are caused by constitutively activated point-mutated fibroblast growth factor receptor 3 (FGFR3) </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have provided a large body of evidence to prove chondrocyte proliferation and differentiation in these disorders </plain></SENT>
<SENT sid="2" pm="."><plain>However, little is known about the possible effects of the FGFR3 mutants on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of chondrocytes </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we analyzed <z:mpath ids='MPATH_3'>apoptosis</z:mpath> using a chondrogenic cell line, ATDC5, expressing the FGFR3 mutants causing ACH and thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, which is a more severe <z:hpo ids='HP_0003811'>neonatal lethal</z:hpo> form comprising type I and type II </plain></SENT>
<SENT sid="4" pm="."><plain>We found that the introduction of these mutated FGFR3s into ATDC5 cells decreased <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of parathyroid hormone-related <z:chebi fb="7" ids="16670">peptide</z:chebi> (PTHrP) and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Importantly, replacement of PTHrP prevented the apoptotic changes in ATDC5 cells expressing ACH mutant </plain></SENT>
<SENT sid="6" pm="."><plain>Insulin-like growth factor (IGF)-I, which is an important mediator of growth hormone (GH), also <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> in ATDC5 cells expressing ACH mutant </plain></SENT>
<SENT sid="7" pm="."><plain>IGF-I prevented <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through the phosphatidylinositol 3-kinase and <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase pathways, indicating the mechanisms by which GH treatment improves disturbed bone growth in ACH </plain></SENT>
</text></document>